This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| EMBASE (Elsevier) | |
|---|---|
| Title | EMBASE |
| Publisher | Elsevier |
| Discipline | Biomedical literature |
| Country | Netherlands |
| Frequency | Continuous |
| History | 1947–present |
EMBASE (Elsevier) EMBASE is a biomedical and pharmacological literature database produced by Elsevier. It serves clinicians, researchers, pharmacists, and policy makers by indexing journal articles, conference abstracts, and regulatory documents across medicine and drug development. Major users include hospitals, universities, pharmaceutical companies, and public health agencies.
EMBASE covers peer-reviewed literature relevant to clinical medicine, pharmacology, toxicology, and health technology. It is comparable to PubMed, Web of Science, Scopus, Cochrane Library, and ClinicalTrials.gov in scope but emphasizes European and pharmacological sources linked to regulatory bodies such as European Medicines Agency, Food and Drug Administration, and World Health Organization. Institutional subscribers include Johns Hopkins University, Mayo Clinic, Imperial College London, Karolinska Institutet, and University of Oxford.
EMBASE originated as Excerpta Medica in 1947, founded amid postwar scientific expansion alongside institutions like Royal Society, Academy of Sciences of the USSR, and publishers such as Elsevier and Springer. Its development paralleled projects from National Institutes of Health, Wellcome Trust, and Medical Research Council. Over decades EMBASE integrated indexing standards influenced by bibliographic initiatives at Library of Congress, National Library of Medicine, and collaborations with academic hubs including Harvard University, Stanford University, and University College London.
EMBASE indexes millions of records from journals, conference proceedings, and regulatory documents. It emphasizes pharmacology, drug adverse events, and European literature with sources from publishers like BMJ Publishing Group, Nature Publishing Group, Wiley-Blackwell, Taylor & Francis, and SAGE Publications. Coverage spans clinical specialties linked to institutions such as Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, UCLA Health, and Mount Sinai Health System. EMBASE includes conference abstracts from meetings organized by American Society of Clinical Oncology, European Society of Cardiology, Infectious Diseases Society of America, American Heart Association, and Society for Neuroscience.
EMBASE uses the Emtree controlled vocabulary to standardize subject headings, analogous to MeSH used by National Library of Medicine. Emtree supports drug synonyms tied to registries like CAS Registry, DrugBank, and regulatory identifiers used by European Medicines Agency and U.S. Food and Drug Administration. Indexing practices align with standards from International Committee of Medical Journal Editors, Committee on Publication Ethics, and metadata frameworks from Dublin Core and ISO standards.
EMBASE is accessible through Elsevier platforms and integrated into discovery systems such as EBSCOhost, Ovid, ProQuest, PubMed Central links, and institutional portals at universities including Columbia University, Yale University, and University of Toronto. Advanced search supports Boolean operators and field tags comparable to Scopus and Web of Science, with filters for study design, population, and publication type used by systematic reviewers at organizations like Cochrane Collaboration, National Institute for Health and Care Excellence, and Agency for Healthcare Research and Quality.
Access to EMBASE is typically by subscription, with licensing arrangements negotiated between Elsevier and consortia such as CHEST, Big Ten Academic Alliance, Russell Group, and national libraries including British Library and Bibliothèque nationale de France. Integrations include linkage to clinical trial registries like ClinicalTrials.gov and pharmacovigilance databases used by European Medicines Agency and U.S. Food and Drug Administration. Institutional access is managed through identity systems like Shibboleth, OpenAthens, and proxy services used by universities including University of California and University of Melbourne.
EMBASE is influential in evidence synthesis, drug safety surveillance, and guideline development conducted by bodies such as World Health Organization, NICE, European Centre for Disease Prevention and Control, Centers for Disease Control and Prevention, and Pan American Health Organization. It is routinely used in systematic reviews published in journals like The Lancet, New England Journal of Medicine, JAMA, BMJ, and Annals of Internal Medicine. Critics and commentators from organizations including Public Library of Science and Open Knowledge Foundation have debated Elsevier licensing practices and access models in relation to open science movements such as Plan S and initiatives like Open Access.
Category:Biomedical databases